Identifying glioblastoma margins using dual-targeted organic nanoparticles for efficient: In vivo fluorescence image-guided photothermal therapy

Xiaolei Cai, Aishwarya Bandla, Chan Kim Chuan, Gayathiri Magarajah, Lun De Liao, Daniel Boon Loong Teh, Brian K. Kennedy, Nitish V Thakor, Bin Liu

Research output: Contribution to journalArticle

Abstract

Current therapeutics for glioblastoma multiforme (GBM) treatment are unsatisfactory due to their limited ability to control the progression from tumour margins. In this work, organic nanoparticles (NPs) are synthesized by co-encapsulating a fluorogen with aggregation-induced emission to generate a bright red emission for imaging and a semiconducting polymer to offer NIR absorption for photothermal therapy. The NPs are further modified with different ratios of two targeting ligands, folate and cRGD peptide. The best ratio that performs specific and efficient GBM targeting is screened out through in vitro and ex vivo fluorescence imaging analysis. The NPs with an FA to cRGD ratio of 25 : 75 exhibit superior ability to target GBM cells in vitro and also show efficient accumulation at the GBM margin and in the tumour interior after in vivo administration. The progression of GBM can be greatly suppressed through photothermal therapy, which provides a simple but promising strategy for GBM treatment.

Original languageEnglish (US)
Pages (from-to)311-317
Number of pages7
JournalMaterials Horizons
Volume6
Issue number2
DOIs
StatePublished - Feb 1 2019
Externally publishedYes

Fingerprint

Fluorescence
Nanoparticles
Tumors
Semiconducting polymers
Imaging techniques
Folic Acid
Peptides
Agglomeration
Ligands
cyclic arginine-glycine-aspartic acid peptide

ASJC Scopus subject areas

  • Materials Science(all)
  • Mechanics of Materials
  • Process Chemistry and Technology
  • Electrical and Electronic Engineering

Cite this

Identifying glioblastoma margins using dual-targeted organic nanoparticles for efficient : In vivo fluorescence image-guided photothermal therapy. / Cai, Xiaolei; Bandla, Aishwarya; Chuan, Chan Kim; Magarajah, Gayathiri; Liao, Lun De; Teh, Daniel Boon Loong; Kennedy, Brian K.; Thakor, Nitish V; Liu, Bin.

In: Materials Horizons, Vol. 6, No. 2, 01.02.2019, p. 311-317.

Research output: Contribution to journalArticle

Cai, Xiaolei ; Bandla, Aishwarya ; Chuan, Chan Kim ; Magarajah, Gayathiri ; Liao, Lun De ; Teh, Daniel Boon Loong ; Kennedy, Brian K. ; Thakor, Nitish V ; Liu, Bin. / Identifying glioblastoma margins using dual-targeted organic nanoparticles for efficient : In vivo fluorescence image-guided photothermal therapy. In: Materials Horizons. 2019 ; Vol. 6, No. 2. pp. 311-317.
@article{f7af90c00e934a4db86935337cadc374,
title = "Identifying glioblastoma margins using dual-targeted organic nanoparticles for efficient: In vivo fluorescence image-guided photothermal therapy",
abstract = "Current therapeutics for glioblastoma multiforme (GBM) treatment are unsatisfactory due to their limited ability to control the progression from tumour margins. In this work, organic nanoparticles (NPs) are synthesized by co-encapsulating a fluorogen with aggregation-induced emission to generate a bright red emission for imaging and a semiconducting polymer to offer NIR absorption for photothermal therapy. The NPs are further modified with different ratios of two targeting ligands, folate and cRGD peptide. The best ratio that performs specific and efficient GBM targeting is screened out through in vitro and ex vivo fluorescence imaging analysis. The NPs with an FA to cRGD ratio of 25 : 75 exhibit superior ability to target GBM cells in vitro and also show efficient accumulation at the GBM margin and in the tumour interior after in vivo administration. The progression of GBM can be greatly suppressed through photothermal therapy, which provides a simple but promising strategy for GBM treatment.",
author = "Xiaolei Cai and Aishwarya Bandla and Chuan, {Chan Kim} and Gayathiri Magarajah and Liao, {Lun De} and Teh, {Daniel Boon Loong} and Kennedy, {Brian K.} and Thakor, {Nitish V} and Bin Liu",
year = "2019",
month = "2",
day = "1",
doi = "10.1039/c8mh00946e",
language = "English (US)",
volume = "6",
pages = "311--317",
journal = "Materials Horizons",
issn = "2051-6347",
publisher = "Royal Society of Chemistry",
number = "2",

}

TY - JOUR

T1 - Identifying glioblastoma margins using dual-targeted organic nanoparticles for efficient

T2 - In vivo fluorescence image-guided photothermal therapy

AU - Cai, Xiaolei

AU - Bandla, Aishwarya

AU - Chuan, Chan Kim

AU - Magarajah, Gayathiri

AU - Liao, Lun De

AU - Teh, Daniel Boon Loong

AU - Kennedy, Brian K.

AU - Thakor, Nitish V

AU - Liu, Bin

PY - 2019/2/1

Y1 - 2019/2/1

N2 - Current therapeutics for glioblastoma multiforme (GBM) treatment are unsatisfactory due to their limited ability to control the progression from tumour margins. In this work, organic nanoparticles (NPs) are synthesized by co-encapsulating a fluorogen with aggregation-induced emission to generate a bright red emission for imaging and a semiconducting polymer to offer NIR absorption for photothermal therapy. The NPs are further modified with different ratios of two targeting ligands, folate and cRGD peptide. The best ratio that performs specific and efficient GBM targeting is screened out through in vitro and ex vivo fluorescence imaging analysis. The NPs with an FA to cRGD ratio of 25 : 75 exhibit superior ability to target GBM cells in vitro and also show efficient accumulation at the GBM margin and in the tumour interior after in vivo administration. The progression of GBM can be greatly suppressed through photothermal therapy, which provides a simple but promising strategy for GBM treatment.

AB - Current therapeutics for glioblastoma multiforme (GBM) treatment are unsatisfactory due to their limited ability to control the progression from tumour margins. In this work, organic nanoparticles (NPs) are synthesized by co-encapsulating a fluorogen with aggregation-induced emission to generate a bright red emission for imaging and a semiconducting polymer to offer NIR absorption for photothermal therapy. The NPs are further modified with different ratios of two targeting ligands, folate and cRGD peptide. The best ratio that performs specific and efficient GBM targeting is screened out through in vitro and ex vivo fluorescence imaging analysis. The NPs with an FA to cRGD ratio of 25 : 75 exhibit superior ability to target GBM cells in vitro and also show efficient accumulation at the GBM margin and in the tumour interior after in vivo administration. The progression of GBM can be greatly suppressed through photothermal therapy, which provides a simple but promising strategy for GBM treatment.

UR - http://www.scopus.com/inward/record.url?scp=85061390489&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061390489&partnerID=8YFLogxK

U2 - 10.1039/c8mh00946e

DO - 10.1039/c8mh00946e

M3 - Article

AN - SCOPUS:85061390489

VL - 6

SP - 311

EP - 317

JO - Materials Horizons

JF - Materials Horizons

SN - 2051-6347

IS - 2

ER -